$CELZ chart looks set up for a run. From looking a
Post# of 350
(Total Views: 509)
Posted On: 05/02/2018 7:24:00 AM
$CELZ chart looks set up for a run. From looking at the chart higher highs, higher lows. Nice dip and accumulation yesterday (expected). Holding for the long.
NEWS FROM APRIL 30, 2018
Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today that debt to two lenders in the amount of $163,000.00 has been retired.
As previously announced Creative Medical Technology Holdings, Inc. has taken on debt in order to advance our technologies and continue towards our goal of commercialization and cash flow.
“We continue to focus on advancing commercialization of our CaverStem™ procedure for the treatment of Erectile Dysfunction and the development of our issued patents for degenerative disc disease (StemSpine™) and our amniotic derived stem cell (AmnioStem™), as well as patents pending in the area of neurological damage due to radiation toxicity and stroke, amongst others. It is also our goal to continue to develop novel approaches to regenerative medicine which will broaden our intellectual property pipeline,” said Timothy Warbington, CEO of Creative Medical Technology Holdings, Inc.
NEWS FROM APRIL 30, 2018
Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today that debt to two lenders in the amount of $163,000.00 has been retired.
As previously announced Creative Medical Technology Holdings, Inc. has taken on debt in order to advance our technologies and continue towards our goal of commercialization and cash flow.
“We continue to focus on advancing commercialization of our CaverStem™ procedure for the treatment of Erectile Dysfunction and the development of our issued patents for degenerative disc disease (StemSpine™) and our amniotic derived stem cell (AmnioStem™), as well as patents pending in the area of neurological damage due to radiation toxicity and stroke, amongst others. It is also our goal to continue to develop novel approaches to regenerative medicine which will broaden our intellectual property pipeline,” said Timothy Warbington, CEO of Creative Medical Technology Holdings, Inc.
(0)
(0)